Vortioxetine for Depressive Symptoms and Freezing of Gait in Parkinson Disease

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

February 28, 2027

Conditions

Parkinson Disease, IdiopathicFreezing of GaitDepression Not Otherwise Specified

Interventions

DRUG

Vortioxetine (tablet)

Vortioxetine will be used with the aim of treating freezing of gait in subjects with Parkinson Disease and depressive symptoms

All Listed Sponsors

lead

Marianna Amboni

OTHER